Abstract
Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia (CLL): A Cross-Trial Comparison
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have